Edwards Lifesciences (EW) Inventory Average (2010 - 2026)

Edwards Lifesciences has reported Inventory Average for 17 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 2.03% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 2.03% YoY), and the FY2025 full-year result was $1.1 billion, up 11.19% from the prior year.
• Inventory Average for Q1 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
• The five-year high for Inventory Average was $1.1 billion in Q3 2025, with the low at $728.6 million in Q1 2022.
• Average Inventory Average over 5 years is $988.4 million, with a median of $1.1 billion recorded in 2024.
• Year-over-year, Inventory Average retreated 7.19% in 2022 and surged 34.37% in 2023.
• Tracing EW's Inventory Average over 5 years: stood at $816.6 million in 2022, then gained by 18.53% to $968.0 million in 2023, then rose by 13.17% to $1.1 billion in 2024, then grew by 3.48% to $1.1 billion in 2025, then decreased by 0.97% to $1.1 billion in 2026.
• The last three Inventory Average figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison